PATIENT RECORD — A-0047
Sample TypeSaliva — 23andMe v5Received
ConsentFull clinical consentSigned
PriorityStandard laboratory workflowProcessing
Chief ComplaintFatigue, inflammation, poor recoveryFlagged
🦉 Hypatia: Sample received. Laboratory and GeneOS processing are underway; your account will update when each verified stage completes.
ALLELIC CONFIGURATION — 847 VARIANTS MAPPED
MTHFR C677T
Heterozygous · MethylationHigh Impact
IL-6 −174G>C
Homozygous · InflammationHigh Impact
COMT Val158Met
Heterozygous · CatecholamineModerate
CYP1B1 Arg48Gly
Heterozygous · DetoxificationModerate
APOE ε3/ε4
Carrier · Lipid MetabolismMonitor
GENETIC BLUEPRINT — READY FOR REVIEW
Priority 1 — Methylation
MTHFR C677T · 35% pathway reduction
Priority 2 — Inflammation
IL-6 elevated · environmental trigger likely
Priority 3 — Detoxification
CYP1B1 · estrogen metabolism affected
⚠ Contraindication: High-dose folic acid (use methylated forms only)
INTERVENTION REVIEW — EVIDENCE-AWARE CONTEXT
Intervention candidates
Reviewed against pathway, medication, allergy, and evidence context
Review
Safety gates
Active medications, phenotype, and contraindication context checked
Gate
Evidence disposition
Scoring, recommendation, research, and safety context remain distinct
Trace
Illustrative review only — GeneOS surfaces rationale and evidence context for clinical review.
RNA EXPRESSION — SAMPLE VIEW
Recovery SignalingOptimal↑
IL-6 Inflammatory Marker14.2 pg/mL↓ 31%
TGF-β Repair Signal+44%↑
Cortisol MetabolitesNormalizing→
✓ Review checkpoint: new measurements are compared with the original assessment and evidence context.